Prot# 97-6475-157: Phase I Trial of Irinotecan (CPT-11) and Gemcitibine in Patients with Solid Tumors (NU Prot# NU 98X3)

Project: Research project

StatusFinished
Effective start/end date5/1/987/31/03

Funding

  • Pharmacia & Upjohn, Inc. (97-6475-157)